Aemetis (NASDAQ:AMTX) Upgraded by Wall Street Zen to Hold Rating

Aemetis (NASDAQ:AMTX) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday.

A number of other equities analysts also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Loop Capital set a $1.75 price target on shares of Aemetis in a research note on Thursday, March 12th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $8.25.

Aemetis Stock Performance

Shares of NASDAQ:AMTX opened at $2.60 on Friday. Aemetis has a twelve month low of $1.22 and a twelve month high of $3.66. The firm has a market cap of $173.24 million, a PE ratio of -1.95 and a beta of 2.61. The business has a fifty day moving average of $1.65 and a 200-day moving average of $1.90.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.04. The company had revenue of $43.31 million for the quarter, compared to analyst estimates of $72.07 million. On average, analysts anticipate that Aemetis will post -2.07 EPS for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Catalyst Funds Management Pty Ltd acquired a new position in Aemetis during the 2nd quarter valued at about $25,000. Creative Planning acquired a new stake in shares of Aemetis during the 2nd quarter worth approximately $30,000. Virtu Financial LLC acquired a new stake in shares of Aemetis during the 4th quarter worth approximately $31,000. HRT Financial LP bought a new stake in shares of Aemetis during the fourth quarter worth approximately $36,000. Finally, Centiva Capital LP bought a new stake in shares of Aemetis during the third quarter worth approximately $39,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.